This post was originally published on this site
(Reuters) – CVS Health Corp (N:) posted a better-than-expected quarterly profit on Wednesday, boosted by its pharmacy benefit management unit and the Aetna (NYSE:) health insurance business it acquired last year.
Shares of the company rose 3% in premarket trading after the company also raised its 2019 adjusted profit forecast range to $6.97 to $7.05 per share, from $6.89 to $7.00.
Sales in the company’s pharmacy services unit increased 6.4% to $36.02 billion in the third quarter, helped by a rise in prices of branded drugs and increased claims.
The company, which also runs drugstores, closed its $69 billion purchase of Aetna in November 2018.
Sales in its health care benefits business, which houses Aetna, soared to $17.18 billion, helped by lower-than-expected medical costs. The unit reported a medical benefit ratio of 83.3%, compared with estimates of 84.3% according to four analysts polled by Refinitiv.
CVS Health’s net profit rose 10.1% to $1.53 billion, or $1.17 per share, in the quarter ended Sept. 30.
Excluding items, the company earned $1.84 per share, above analysts’ estimates of $1.77.
Revenue jumped 36.5% to $64.81 billion.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
